Similar virulence properties of infection and colonization associated Pseudomonas aeruginosa

Aditi1, Malini Shariff1, Sunil K Chhabra2

  • 1Department of Microbiology, Vallabhbhai Patel Chest Institute, Delhi, India.

Abstract

Insights

The presence of the exoU gene in Pseudomonas aeruginosa correlates with severe disease and longer hospital stays. However, virulence factors alone do not necessitate anti-pseudomonal chemotherapy.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa is a common cause of nosocomial infections.
  • Distinguishing between infection and commensal presence is challenging due to its varied carriage sites.
  • Virulence factors are key determinants of P. aeruginosa pathogenicity.

Purpose of the Study:

  • To identify host and organism factors associated with Pseudomonas aeruginosa infection.
  • To investigate the role of specific virulence factors in P. aeruginosa pathogenicity.
  • To correlate genetic profiles and antimicrobial resistance with clinical outcomes.

Main Methods:

  • Analysis of virulence genes (apr, lasB, T3SS effectors, toxA), biofilm production, and antimicrobial susceptibility.
  • Typing of pathogenic, colonizing, and environmental P. aeruginosa isolates using RAPD.
  • Correlation of genetic markers and resistance patterns with patient data.

Main Results:

  • No single virulence factor or antimicrobial susceptibility profile was significantly linked to infection.
  • The exoU gene and multidrug-resistant (MDR) strains correlated with longer hospital stays.
  • exoU and exoS gene positivity strongly correlated with multidrug resistance and fluoroquinolone resistance.
  • Sink environments in healthcare settings were identified as reservoirs for extensively drug-resistant (XDR) P. aeruginosa.

Conclusions:

  • exoU gene positivity in P. aeruginosa is associated with severe disease and prolonged hospitalization.
  • Presence of virulence factors or MDR strains should not automatically trigger anti-pseudomonal chemotherapy.
  • Further research is needed to guide targeted therapeutic interventions for P. aeruginosa infections.